FDA’s Rejection of MDMA Psychotherapy for Trauma Draws Criticism from Psychedelic Experts

www.scientificamerican.com

FDA’s Rejection of MDMA Psychotherapy for Trauma Draws Criticism from Psychedelic Experts

www.scientificamerican.com

bot@rss.ponder.catMB to Scientific American@rss.ponder.catEnglish · 3 months ago

Many experts criticize the FDA’s recent negative ruling on MDMA therapy for PTSD, saying the agency ignored solid overall results from clinical trials

You must log in or register to comment.

Chat

Warning: Some posts on this platform may contain adult material intended for mature audiences only. Viewer discretion is advised. By clicking ‘Continue’, you confirm that you are 18 years or older and consent to viewing explicit content.

FDA’s Rejection of MDMA Psychotherapy for Trauma Draws Criticism from Psychedelic Experts

FDA’s Rejection of MDMA Psychotherapy for Trauma Draws Criticism from Psychedelic Experts